Establishment of a prediction system for adverse events of chemoradiotherapy in older patients with head and neck, esophageal and lung cancer.

Establishment of a prediction system for adverse events of chemoradiotherapy in older patients with head and neck, esophageal and lung cancer. - Establishment of a prediction system for adverse events of chemoradiotherapy in older patients with head and neck, esophageal and lung cancer.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056052

Enrollment

300

Registered

2024-11-05

Start date

2024-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer, Esophageal cancer, Lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients are eligible for definitive radiation therapy as initial treatment, excluding patient background such as age and comorbidities. 2. Patients received sufficient explanation before participating in this study, and obtained written consent by the patient himself / herself with sufficient understanding.

Exclusion criteria

Exclusion criteria: 1. Patients with difficulty returning to the hospital where they were treated for at least three months after treatment. 2. Patients with difficulty in maintaining the treatment position. 3. Patients with recurrent disease. 4. Patient or his / her family cannot evaluate the patient's Geriatric assessment. 5. Patients were judged by the principal investigator to be inappropriate as subjects.

Design outcomes

Primary

Measure	Time frame
Predict factors of grade 3 or higher acute adverse events	—

Secondary

Measure	Time frame
1. Change of treatment policy (radiotherapy and/or concurrent chemotherapy) and their predictors 2. Completion of planned radiotherapy and/or concurrent chemotherapy and their predictors 3. Rate of planned radiotherapy and/or concurrent chemotherapy not completed	—

Countries

Japan

Contacts

Public ContactKeiko Murofushi

Tokyo Metropolitan Cancer and Infectious Center Komagome Hospital Department of Radiology

kmurofushi0918@gmail.com03-3823-2101

Outcome results